Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent ...
Metsera Inc. (MTSR), a New York-based biotech that went public on Jan. 31 with some fanfare, has a full portfolio of weight-loss drugs in development, using both the hormones already used in existing ...
Whether you’re trying to lose weight or dodge diabetes, this once-unsung dietary hero is the ultimate nutritional silver ...
Drugs approved for diabetes and obesity might be useful for the treatment of cognitive and mental health disorders, according ...
A target trial emulation study compared risk for depression among older adults with type 2 diabetes initiating treatment with ...
Data submitted to the UK drugs regulator show a total of 82 deaths related to glucagon-like peptide-1 receptor agonists, the class of drugs used for weight loss and type 2 diabetes. Data from the ...
Hosted on MSN11h
Thyroid Cancer Is Overdiagnosed in the U.S.—Could Ozempic Be Making the Problem Worse?Fact checked by Nick Blackmer Weight loss drugs like Ozempic may be contributing to a national trend of thyroid cancer ...
(res), a leading physician-developed supplement brand, announced today the launch of their latest product innovation, resM™ ...
11h
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...
GLP-1 receptor agonists are transforming obesity treatment, but manufacturing challenges must be addressed to meet rising ...
New 7.5 mg and 10 mg Zepbound single-dose vials now available for $499 per month via Zepbound Self Pay Journey Program 2.5 mg and 5 mg vial prices reduced INDIANAPOLIS ...
GLP-1 RAs show protective effects against primary open-angle glaucoma and ocular hypertension, surpassing alternative weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback